Inhaled nitric oxide: clinical applications, indications, and toxicology. - Wikidata - wikimedia - TriplyDB

Inhaled nitric oxide: clinical applications, indications, and toxicology.

Inhaled nitric oxide: clinical applications, indications, and toxicology.

http://www.wikidata.org/entity/Q38556138

about

Mechanisms of acute brain injury after subarachnoid hemorrhage.A randomized clinical trial testing the anti-inflammatory effects of preemptive inhaled nitric oxide in human liver transplantation.Increased resting heart rate with pollutants in a population based study.Arterial pulmonary hypertension in noncardiac intensive care unit.Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment.Pharmacotherapy of acute lung injury and acute respiratory distress syndrome Inhaled nitric oxide and the risk of renal dysfunction in patients with acute respiratory distress syndrome: a propensity-matched cohort study.The management of acute pulmonary arterial hypertension.Gaseous therapeutics in acute lung injury.What is the clinical significance of pulmonary hypertension in acute respiratory distress syndrome? A review.Tadalafil: Protective Action against the Development of Multiple Organ Failure Syndrome.DA-8159, a new PDE5 inhibitor, attenuates the development of compensatory right ventricular hypertrophy in a rat model of pulmonary hypertension.

P2860

Q34535638-2FF5F444-23E4-41C2-940C-20143B1A0010 Q35095236-65E61C99-5BDE-4036-AD68-66264925BFDC Q35419662-3F1BB45C-EB4C-4B97-91D5-FA63974212D2 Q37019853-2F0B959F-9F05-46A6-833C-5AA54E7AA6AC Q37045664-58149761-6B46-48E1-A911-803679B0AC57 Q37085611-8D2A2FAE-B806-49E4-BD57-90066FF2F2AD Q37460471-A0B6E458-7136-4A21-8262-85AF7B6C5CE9 Q37766261-3ED54088-EE49-4CAE-AD8E-1CE94EED27BF Q38112031-B8078735-D9B7-449A-ABD5-666B7A325B1B Q38160168-50894971-5A6F-4F70-A7ED-5377FC4606C0 Q41770224-82EF511A-4118-4781-8E5F-31C5749CD738 Q44715956-A9101A3E-B713-48B5-88D0-B47DEAE096EB

P2860

Inhaled nitric oxide: clinical applications, indications, and toxicology.

http://www.wikidata.org/entity/Q38556138

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Inhaled nitric oxide: clinical applications, indications, and toxicology.

@en

type

label

Inhaled nitric oxide: clinical applications, indications, and toxicology.

@en

prefLabel

Inhaled nitric oxide: clinical applications, indications, and toxicology.

@en

P1433

Q38556138-77B50AC2-839E-4AC1-983D-568D34D1E449

P1476

Q38556138-888D9D93-0B28-4C2B-94F4-C66E31F7175C

P2093

Q38556138-2329C403-3693-4F9A-8939-5AD4857ADEA9

Q38556138-C70453A5-A943-4CE2-8EB7-D7BCBB52BD7D

P2860

Q38556138-22354C72-BD32-433C-A3DB-FCDDFAB2ECB2

Q38556138-25298678-4E7D-4141-BE84-0D7164C03FA3

Q38556138-2A12FCE9-45C8-47C8-91C5-336DE4310EB6

Q38556138-4ED2B7E9-0209-4B5D-BFE1-E9F9137DC90E

Q38556138-6A85FE96-F9C9-4BD9-BC71-0D6476B3F03E

Q38556138-709F8277-4E41-446E-ACC8-532070CD2E50

Q38556138-88204F71-5311-4906-B251-BC430182A04F

Q38556138-8CFBD47D-7D15-4E40-AB7C-401B9A4149E0

Q38556138-E94B0AF9-2325-4F95-BF8C-3931193F93C9

Q38556138-ED6BEBD4-6EB4-4A21-B74F-929D48EA81B1

P2888

Q38556138-7FC0914B-215D-4889-A7DD-BD37155BDBF0

P304

Q38556138-2BD3C827-F836-4A3E-8D1E-83309061A197

P31

Q38556138-F63FB479-48E8-4E4F-BAB7-B937F44ED1BC

P356

Q38556138-0BA541BF-4E69-48DF-84BC-0DCE0DE7E650

P433

Q38556138-9F730D18-5B57-48CA-849F-52614F357EA7

P478

Q38556138-354165D9-E4BC-4D83-9D31-A33411D47B31

P50

Q38556138-7807AD17-1C5C-4163-86E1-43E045330F95

P577

Q38556138-7547828A-C1D0-41E8-ABF4-8D6EFD0E171D

P6179

Q38556138-BAD56DF9-8AED-4AFA-8AD6-FEEBD6763069

P698

Q38556138-5A1FBF8D-216E-47FE-978A-B414A0FB76F7

P356

P1433

Canadian Journal of Anaesthesia

P1476

Inhaled nitric oxide: clinical applications, indications, and toxicology

@en

P2093

G Blaise

http://www.w3.org/2001/XMLSchema#string

M Francoeur

http://www.w3.org/2001/XMLSchema#string

P2860

The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination

An expanded definition of the adult respiratory distress syndrome.

Nitric oxide and cardiac function.

EMERGENCY EXPOSURE LIMITS: NITROGEN DIOXIDE; 1,1-DIMETHYLHYDRAZINE; 1,1,1-TRICHLOROETHANE.

Improvement in pulmonary hypertension and hypoxemia during nitric oxide inhalation in a patient with end-stage pulmonary fibrosis.

Combination of inhaled nitric oxide with i.v. nitroglycerin or with a prostacyclin analogue in the treatment of experimental pulmonary hypertension.

Factors influencing cardiopulmonary effects of inhaled nitric oxide in acute respiratory failure.

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

Inhalation of nitric oxide modulates adult human bronchial tone.

Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension.

P2888

P304

973-988

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF03011970

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

P577

1997-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1047403601

http://www.w3.org/2001/XMLSchema#string

P698

9305562

http://www.w3.org/2001/XMLSchema#string